Cantharidin suppresses hepatocellular carcinoma development by regulating EZH2/H3K27me3-dependent cell cycle progression and antitumour immune response

BACKGROUND: Cantharidin (CTD) is a major ingredient of cantharis (Mylabris phalerata Pallas) and has been used extensively in traditional Chinese medicines. It has been shown to exhibit anticancer activity in multiple types of cancer, especially hepatocellular carcinoma (HCC). However, there is no s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jia, Deng, Xiu ling, Ma, Shi qi, hui Li, Yu, Gao, Yu min, Shi, Gui tao, Wang, Hai sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193799/
https://www.ncbi.nlm.nih.gov/pubmed/37202806
http://dx.doi.org/10.1186/s12906-023-03975-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193799/
https://www.ncbi.nlm.nih.gov/pubmed/37202806
http://dx.doi.org/10.1186/s12906-023-03975-0

Ejemplares similares